Haylin Loo

Haylin Loo

Auto-generated profile, based on publicly available information

Haylin Loo

Médico Ocupacional Asociación entre características de las calcificaciones mamográficas y neoplasia maligna en un hospital nacional 2017

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
JOJ.-P. Olié
J.-P. Olié
FMF. Mouaffak
F. Mouaffak
MKMarie-Odile Krebs
Marie-Odile Krebs
HLH. Lôo
H. Lôo

12 January 2016 in L'Encéphale
Verified
Journal Article
Closed access
MMM. Masson
M. Masson
RGR. Gaillard
R. Gaillard
JOJ.-P. Olié
J.-P. Olié
HLH. Lôo
H. Lôo


12 January 2021 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
JAJennyfer E. Garcia Arispe
Jennyfer E. Garcia Arispe
MLMaría Loo-Valverde
María Loo-Valverde
WCWiller Chanduví
Willer Chanduví
JRJOSE MANUEL VELA RUIZ
JOSE MANUEL VELA RUIZ
RGRocio Guillen-Ponce
Rocio Guillen-Ponce
Jhony De La Cruz VargasJhony De La Cruz Vargas
Jhony De La Cruz Vargas
Objective: To determine the relationship between anemia and 5-year survival in cancer patients. Materials and methods: Observational, analytical, and retrospective cohort study. The sample population consisted of novel diagnosed cancer patients registered for hospital care with their respective follow up from 2014 until 2019. Time to death, presence of anemia, and other variables were evaluated. Survival was determined using Kaplan Meier curves and analyzed using the log-rank test. Hazard ratio and risk were determined in turn using the Cox regression model. Results: 72 patients were included in the study, 79.2% of which correspond to solid neoplasms. Anemia was present at the time of diagnosis in 45.8% of patients. Statistically significant differences were found on survival curves for anemia, severity graded anemia, age, and clinical stage. Anemia showed a significant relation with survival (HR: 3.03; CI: 95; p <0.05) on the adjusted bivariate and multivariate analysis for age over 70 years. Likewise, on the respective adjusted analysis for age and clinical stage, anemia showed a significant relation with survival on patients with solid neoplasms. Overall, 30.3% of patients received some type of treatment for anemia. Conclusion: Anemia is frequently found in cancer patients and is significantly related to 5-year overall survival. Age over 70 and severe anemias were related to higher mortality of cancer patients. Objetivo: Determinar la relación entre la anemia y la supervivencia a 5 años en pacientes con cáncer. Materiales y métodos: Estudio de cohorte observacional, analítico y retrospectivo. La población de la muestra consistió en pacientes con un nuevo diagnóstico de cáncer registrados para su atención hospitalaria con su respectivo seguimiento desde 2014 hasta 2019. Se evaluó el tiempo hasta la muerte, la presencia de anemia y otras variables. La supervivencia se determinó usando las curvas de Kaplan Meier y se analizó usando la prueba de rango logarítmico. La proporción de peligro y riesgo se determinó a su vez usando el modelo de regresión de Cox. Resultados: Se incluyeron 72 pacientes en el estudio, de los cuales el 79,2% corresponde a neoplasias sólidas. La anemia estaba presente en el momento del diagnóstico en el 45,8% de los pacientes. Se encontraron diferencias estadísticamente significativas en las curvas de supervivencia de la anemia, en el grado de severidad de la anemia, en la edad y en la etapa clínica. La anemia mostró una relación significativa con la supervivencia (HR: 3,03; CI: 95; p <0,05) en el análisis bivariante y multivariante ajustado para la edad de más de 70 años. Asimismo, en los respectivos análisis ajustados por edad y estadio clínico, la anemia mostró una relación significativa con la supervivencia en pacientes con neoplasias sólidas. En general, el 30,3% de los pacientes recibieron algún tipo de tratamiento para la anemia. Conclusión: La anemia se encuentra frecuentemente en pacientes con cáncer y está significativamente relacionada con la supervivencia global a 5 años. La edad superior a los 70 años y las anemias graves se relacionaron con una mayor mortalidad de los pacientes de cáncer.

1 January 1993 in European Psychiatry
Verified
Journal Article
Closed access
PDF file
JFJd Favre
Jd Favre
HLH Lôo
H Lôo
CMC Marey
C Marey
BDB Delalleau
B Delalleau
Tianeptine, whose main neurochemical action is to increase 5-HT uptake, significantly decreased alcohol consumption in rats. During a tianeptine long-term treatment study, gamma-GT levels in depressed alcoholic patients decreased, suggesting that this medication could be useful in alcoholism. The role of tianeptine in the prevention of alcoholic relapses is being evaluated in a double-blind placebo-controlled study. Two hundred non-depressed patients satisfying DSM III-R criteria for Psychoactive Substance Dependence (alcohol – daily intake greater than 80 g) will enter the study after alcohol withdrawal. A minimum score of three on the Short-Mast Questionnaire, mean cell volume above 98 f1 and/or gamma-GT more than twice the upper normal value are required. Patients are treated as out-patients and surveyed for 9 months. The maintenance of abstinence is estimated through clinical and laboratory assessments. The alcohol intake is evaluated in patients who relapse. Efficacy is determined secondarily using Clinical Global Impressions Scale, Hopkins Symptom Check List and visual analogue scales. Somatic complaints are collected using AMDP-5. Preliminary results are presented.

1 October 2009 in L'Encéphale
Verified
Journal Article
Closed access
HLH. Lôo
H. Lôo